1Beisiegel, U, Weber, W, Ihrke, G, et al. (1989) The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341, 162–164.
2Weisgraber, KH (1994) Apolipoprotein E: structure-function relationships. Adv Protein Chem 45, 249–302.
3Miettinen, TA, Gylling, H, Vanhanen, H, et al. (1992) Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 12, 1044–1052.
4Dallongeville, J, Lussier-Cacan, S & Davignon, J (1992) Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 33, 447–454.
5Wilson, PW, Myers, RH, Larson, MG, et al. (1994) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. J Am Med Assoc 272, 1666–1671.
6Siest, G, Pillot, T, Regis-Bailly, A, et al. (1995) Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 41, 1068–1086.
7Huang, Y, Liu, XQ, Rall, SC Jr, et al. (1998) Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem 273, 26388–26393.
8Gracia, V, Fiol, C, Hurtado, I, et al. (1994) An enzyme-linked immunosorbent assay method to measure human apolipoprotein E levels using commercially available reagents: effect of apolipoprotein E polymorphism on serum apolipoprotein E concentration. Anal Biochem 223, 212–217.
9Taddei, K, Clarnette, R, Gandy, SE, et al. (1997) Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. Neurosci Lett 223, 29–32.
10Havel, RJ & Kane, JP (1973) Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc Natl Acad Sci U S A 70, 2015–2019.
11Curry, MD, McConathy, WJ, Alaupovic, P, et al. (1976) Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta 439, 413–425.
12Kushwaha, RS, Hazzard, WR, Wahl, PW, et al. (1977) Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein-E immunoassay. Ann Intern Med 87, 509–516.
13Morrisett, JD, Kim, HS, Patsch, JR, et al. (1982) Genetic susceptibility and resistance to diet-induced atherosclerosis and hyperlipoproteinemia. Arteriosclerosis 2, 312–324.
14Lambert, JC, Brousseau, T, Defosse, V, et al. (2000) Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations – the ECTIM study. Hum Mol Genet 9, 57–61.
15Corbo, RM, Vilardo, T, Ruggeri, M, et al. (1999) Apolipoprotein E genotype and plasma levels in coronary artery disease. A case–control study in the Italian population. Clin Biochem 32, 217–222.
16Corbo, RM, Vilardo, T, Mantuano, E, et al. (1997) Apolipoproteins B and E, and angiotensin I-converting enzyme (ACE) genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels. Clin Genet 52, 77–82.
17Schwartzkopff, W, Schleicher, J, Pottins, I, et al. (1990) Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarction. Atherosclerosis 82, 253–259.
18Lee, SJ, Moye, LA & Campos, H (2003) Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease. Atherosclerosis 167, 293–302.
19Syvanne, M, Rosseneu, M, Labeur, C, et al. (1994) Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report. Atherosclerosis 105, 25–34.
20Vincent-Viry, M, Schiele, F, Gueguen, R, et al. (1998) Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. Clin Chem 44, 957–965.
21Neale, MC, de Knijff, P, Havekes, LM, et al. (2000) ApoE polymorphism accounts for only part of the genetic variation in quantitative ApoE levels. Genet Epidemiol 18, 331–340.
22Patsch, W, Gotto, AM Jr & Patsch, JR (1986) Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. J Biol Chem 261, 9603–9606.
23Innerarity, TL & Mahley, RW (1978) Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry 17, 1440–1447.
24Mahley, RW (1982) Atherogenic hyperlipoproteinemia. The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. Med Clin North Am 66, 375–402.
25Reue, KL, Quon, DH, O'Donnell, KA, et al. (1984) Cloning and regulation of messenger RNA for mouse apolipoprotein E. J Biol Chem 259, 2100–2107.
26Phillips, NR, Havel, RJ & Kane, JP (1983) Sex-related differences in the concentrations of apolipoprotein E in human blood plasma and plasma lipoproteins. J Lipid Res 24, 1525–1531.
27Havel, RJ, Kotite, L, Vigne, JL, et al. (1980) Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency. J Clin Invest 66, 1351–1362.
28Noma, A, Hata, Y & Goto, Y (1991) Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: reference values, and age- and sex-related differences. Clin Chim Acta 199, 147–157.
29Rifai, N, McMurray, RG & Silverman, LM (1987) The effects of the behavioral patterns on lipoprotein profile. Clin Chim Acta 169, 333–335.
30Au, YP, Bren, ND & Kottke, BA (1986) A rapid apolipoprotein E radioimmunoassay using solid-phase staphylococcus protein. Use of pooled plasma as a secondary standard. Biochem Biophys Res Commun 138, 455–462.
31Human Nutrition Information Service DoACoF (1987) Agriculture Handbook No. 8. Washington, DC: US Government Printing Office.
32Varela, G (1980) Food Composition Tables (Tablas de composición de alimentos). Madrid: Instituto de Nutrición CSIC.
33Association of Official Analytical Chemists (1990) Official Methods of Analysis, 15th ed.Aarlington, VA: Association of Official Analytical Chemists.
34Ruiz-Gutierrez, V, Prada, JL & Perez-Jimenez, F (1993) Determination of fatty acid and triacylglycerol composition of human very-low-density lipoproteins. J Chromatogr 622, 117–124.
35Allain, CC, Poon, LS, Chan, CS, et al. (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20, 470–475.
36Bucolo, G & David, H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19, 476–482.
37Assmann, G, Schriewer, H, Schmitz, G, et al. (1983) Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem 29, 2026–2030.
38Riepponen, P, Marniemi, J & Rautaoja, T (1987) Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest 47, 739–744.
39Friedewald, WT, Levy, RI & Fredrickson, DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
40Luc, G, Bard, JM, Arveiler, D, et al. (1994) Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 14, 1412–1419.
41Nakai, K, Fusazaki, T, Zhang, T, et al. (1998) Polymorphism of the apolipoprotein E and angiotensin I converting enzyme genes in Japanese patients with myocardial infarction. Coron Artery Dis 9, 329–334.
42Tiret, L, de Knijff, P, Menzel, HJ, et al. (1994) ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb 14, 1617–1624.
43Bohnet, K, Pillot, T, Visvikis, S, et al. (1996) Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. J Lipid Res 37, 1316–1324.
44Srivastava, RA, Srivastava, N, Averna, M, et al. (1997) Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J Biol Chem 272, 33360–33366.
45Reilly, SL, Ferrell, RE, Kottke, BA, et al. (1992) The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester. Minnesota. II. Regression relationships with concomitants. Am J Hum Genet 51, 1311–1324.
46Schiele, F, De Bacquer, D, Vincent-Viry, M, et al. (2000) Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis 152, 475–488.
47Johansson, S, Bondjers, G, Fager, G, et al. (1988) Serum lipids and apolipoprotein levels in women with acute myocardial infarction. Arteriosclerosis 8, 742–749.
48Chivot, L, Mainard, F, Bigot, E, et al. (1990) Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E. Atherosclerosis 82, 205–211.
49Sacks, FM, Alaupovic, P, Moye, LA, et al. (2000) VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation 102, 1886–1892.
50Fielding, CJ, Reaven, GM & Fielding, PE (1982) Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E. Proc Natl Acad Sci U S A 79, 6365–6369.
51Weisweiler, P & Schwandt, P (1987) Type 1 (insulin-dependent) versus type 2 (non-insulin-dependent) diabetes mellitus: characterization of serum lipoprotein alterations. Eur J Clin Invest 17, 87–91.
52Huang, Y, Liu, XQ, Rall, SC Jr, et al. (1998) Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins. J Biol Chem 273, 17483–17490.
53Rensen, PC, Herijgers, N, Netscher, MH, et al. (1997) Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J Lipid Res 38, 1070–1084.
54Srivastava, RA (1996) Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and post-transcriptional mechanisms. Mol Cell Biochem 155, 153–162.
55Jackson, KG, Wolstencroft, EJ, Bateman, PA, et al. (2005) Greater enrichment of triacylglycerol-rich lipoproteins with apolipoproteins E and C-III after meals rich in saturated fatty acids than after meals rich in unsaturated fatty acids. Am J Clin Nutr 81, 25–34.
56Schiele, F, Vincent-Viry, M, Starck, M, et al. (2002) Apolipoprotein E in apolipoprotein B (apo B)- and non-apo B-containing lipoproteins in 3523 participants in the Stanislas cohort: biological variation and genotype-specific reference limits. Clin Chem 48, 291–300.